<DOC>
	<DOCNO>NCT00500500</DOCNO>
	<brief_summary>The aim study measure effect EGb 761® versus placebo ratio isoform protein precursor beta amyloid platelet , patient mild moderate Alzheimer 's disease .</brief_summary>
	<brief_title>Effect EGb 761® Patients With Mild Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>female male 50 85 year old care giver Mini Mental Status ( MMS ) test 16 26 inclusive Clinical Dementia Rating ( CDR ) test inferior equal 1 National Institute Neurological Communicative Disorders Stroke / Alzheimer 's Disease Related Disorders Association ( NINCDS/ADRDA ) test positive Alzheimer 's disease Diagnostic Statistical Manual Mental Disorders , 4th Edition ( DSM IV ) test positive dementia patient already treat medicine could interfere study low level vitamin B12 folate consider clinically relevant clinically relevant pathology ( eg : pulmonary illness , cardiovascular illness ; evolutive cancer , neurological illness , blood illness… . )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>